Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
Elke Tatjana Aristizabal Prada(Ludwig-Maximilians-Universität München), Christoph J. Auernhammer(LMU Klinikum)
Cited by 32
Related Papers
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Pituitary Corticotroph SOCS-3: Novel Intracellular Regulation of Leukemia-Inhibitory Factor-Mediated Proopiomelanocortin Gene Expression and Adrenocorticotropin Secretion
|Molecular Endocrinology|1998|91
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
|Cancers|2020|39
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro
|Neuroendocrinology|2017|23
SOCS Proteins: Modulators of Neuroimmunoendocrine Functions: Impact on Corticotroph LIF Signaling
|Annals of the New York Academy of Sciences|2000|18